- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Amy Berman, RN, Discusses the Importance of Patient-Centered Care in Oncology
For people who have cancer, patient-centered care is particularly important because their life is changing, said Amy Berman, RN, BS, senior program officer at the John A. Hartford Foundation, who also has stage 4 breast cancer.
For people who have cancer, patient-centered care is particularly important because their life is changing, Amy Berman, RN, BS, senior program officer at the John A. Hartford Foundation, who also has stage 4 breast cancer, said at The American Journal of Managed Care’s Patient-Centered Oncology Meeting 2014.
For many cancer patients, they are going to be living with the disease for a very long time, so they need to understand how to maintain their health and keep a positive attitude. And it’s important to keep the family involved.
“Cancer is one of those all-encompassing diseases that affects not just the person but their family, and providers need to understand, you know, what’s the best way to help that person do as well as possible,” she said.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
